Welcome to LookChem.com Sign In|Join Free

CAS

  • or
phenyl 4-oxo-3,4-dihydro-1(2H)-pyridinecarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

121507-66-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 121507-66-2 Structure
  • Basic information

    1. Product Name: phenyl 4-oxo-3,4-dihydro-1(2H)-pyridinecarboxylate
    2. Synonyms: phenyl 4-oxo-3,4-dihydro-1(2H)-pyridinecarboxylate
    3. CAS NO:121507-66-2
    4. Molecular Formula: C12H11NO3
    5. Molecular Weight: 217.22064
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 121507-66-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: phenyl 4-oxo-3,4-dihydro-1(2H)-pyridinecarboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: phenyl 4-oxo-3,4-dihydro-1(2H)-pyridinecarboxylate(121507-66-2)
    11. EPA Substance Registry System: phenyl 4-oxo-3,4-dihydro-1(2H)-pyridinecarboxylate(121507-66-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 121507-66-2(Hazardous Substances Data)

121507-66-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 121507-66-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,5,0 and 7 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 121507-66:
(8*1)+(7*2)+(6*1)+(5*5)+(4*0)+(3*7)+(2*6)+(1*6)=92
92 % 10 = 2
So 121507-66-2 is a valid CAS Registry Number.

121507-66-2Relevant articles and documents

Catalytic enantioselective conjugate addition of dialkylzinc reagents to N-substituted-2,3-dehydro-4-piperidones

Sebesta, Radovan,Pizzuti, Maria Gabriella,Boersma, Arnold J.,Minnaard, Adriaan J.,Feringa, Ben L.

, p. 1711 - 1713 (2005)

The first, highly enantioselective, copper/phosphoramidite-catalyzed conjugate addition of dialkylzinc reagents to N-substituted 2,3-dehydro-4- piperidones is described. The Royal Society of Chemistry 2005.

New oxidative demetalation protocol for molybdenum π-complexes: Enantiocontrolled synthesis of unsaturated ketones and lactones

Alcudia, Ana,Arrayas, Ramon Gomez,Liebeskind, Lanny S.

, p. 5773 - 5778 (2002)

An efficient and general oxidative demetalation of (η3-allyl)molybdenum complexes using pyridinium dichromate allows the introduction of a carbonyl group at an allylic terminus of the π-system. The process takes place with high regiocontrol and can lead to the preparation of unsaturated ketones and lactones of high enantiopurity.

Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics

Hillisch, Alexander,Gericke, Kersten M.,Allerheiligen, Swen,Roehrig, Susanne,Schaefer, Martina,Tersteegen, Adrian,Schulz, Simone,Lienau, Philip,Gnoth, Mark,Puetter, Vera,Hillig, Roman C.,Heitmeier, Stefan

supporting information, p. 12574 - 12594 (2020/11/13)

Despite extensive research on small molecule thrombin inhibitors for oral application in the past decades, only a single double prodrug with very modest oral bioavailability has reached human therapy as a marketed drug. We have undertaken major efforts to identify neutral, non-prodrug inhibitors. Using a holistic analysis of all available internal data, we were able to build computational models and apply these for the selection of a lead series with the highest possibility of achieving oral bioavailability. In our design, we relied on protein structure knowledge to address potency and identified a small window of favorable physicochemical properties to balance absorption and metabolic stability. Protein structure information on the pregnane X receptor helped in overcoming a persistent cytochrome P450 3A4 induction problem. The selected compound series was optimized to a highly potent, neutral, non-prodrug thrombin inhibitor by designing, synthesizing, and testing derivatives. The resulting optimized compound, BAY1217224, has reached first clinical trials, which have confirmed the desired pharmacokinetic properties.

REGIO- AND STEREOSELECTIVE ADDITION OF NUCLEOPHILES TO 1-PHENOXYCARBONYL-2,3-DIHYDROPYRIDINIUM SALTS

Comins, Daniel L.,Chung, Geewon,Foley, Michael, A.

, p. 1121 - 1140 (2007/10/02)

Several 2-alkyl-1-phenoxycarbonyl-Δ3-piperidines were prepared by the addition of alkylzinc iodides to dihydropyridinium salt (9).The treatment of 4-hydroxy-2-methyl-1-phenoxycarbonyl-1,2,3,4-tetrahydropyridine (12) with allyltrimethylsilane in the presence of a variety of Lewis acids was studied and found to give cis- and trans-2,6-dialkyl-Δ3-piperidines (14) and (15) in moderate to good yield.Among the Lewis acids studied, stannyl chloride gave the best yield with good stereoselectivity (84:16) favoring the cis-isomer (14).The analogous reaction of the 4-metho xy derivative (13) with organozinc reagents was examined and found to give the cis-isomers (17) as the major products.Using this metodology, the cis-piperidine alkaloid (+/-)-dihydropinidine, was prepared in six steps from 4-methoxypyridine.

THE ADDITION OF ALKYLZINC IODIDES TO 1-(PHENOXYCARBONYL)-2,3-DIHYDROPYRIDINIUM SALTS. A SYNTHESIS OF 2-ALKYL-Δ3-PIPERIDINES.

Comins, Daniel L.,Foley, Michael A.

, p. 6711 - 6714 (2007/10/02)

Several 2-alkyl-1-(phenoxycarbonyl)-Δ3-piperidines were prepared by the addition of alkylzinc iodides to 1-(phenoxycarbonyl)-2,3-dihydropyridinium salts.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121507-66-2